ArticleAmerican heart journal plus : cardiology research and practice2026
Novel cholesterol lowering drugs: Can phase 2/3 clinical trial safety assessments predict cardiovascular event outcome trial efficacy?
Charles Shear et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.